ATLANTA, GA – – (Globe Newswire – April 23, 2024) – – A shareholder class action lawsuit has been filed against Global Cord Blood Corporation (“Global Cord” or the “Company”) (NYSE: CO). The lawsuit alleges that Defendants made materially false and misleading statements and/or failed to disclose material adverse information regarding the Company’s business, operations, and prospects, including allegations that Global Cord employed a capital allocation strategy designed to reserve funds for Company insiders and related parties rather than for the benefit of Company shareholders.

If you bought Global Cord shares between June 4, 2019 and May 3, 2022, and suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Marshall Dees, Esq. at mdees@holzerlaw.com, by toll-free telephone at (888)-508-6832 or, you may visit the firm’s website at www.holzerlaw.com/case/global-cord-blood/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is June 24, 2024.